证券代码：603856 证券简称：东宏股份 公告编号：2025-032 山东东宏管业股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 经中国证券监督管理委员会出具的《关于同意山东东宏管业股份有限公司向特定对象发行股票注册的批 复》（证监许可〔2024〕228号），同意山东东宏管业股份有限公司（以下简称"公司"）向特定对象发 行股票的注册申请，公司已完成向特定对象发行人民币普通股（A股）25,641,460股，公司注册资本由 人民币256,414,600元变更为282,056,060元，公司总股本由256,414,600股变更为282,056,060股。 公司分别于2025年4月23日、2025年5月15日召开第四届董事会第十八次会议、2024年年度股东大会，审 议通过了《关于变更注册资本及修订〈公司章程〉的议案》，具体内容详见公司于2025年4月25日、 2025年5月16日在上海证券交易所网站（www.sse.com.cn）披露的《东宏股份关于变更注册资本及修订 〈公司章 ...

证券代码：600166 证券简称：福田汽车 编号：临2025一046 北汽福田汽车股份有限公司 关于调整相关高级管理人员的公告 公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 一、高级管理人员离任情况 （一）提前离任的基本情况 ■ （二）离任对公司的影响 巩海东同志不存在应当履行而未履行的承诺事项，并已按照公司相关规定做好交接工作，其离任副总经 理职务不会影响公司的正常经营；巩海东同志本次不再担任公司副总经理职务后，除了其所兼任的外派 董监事职务尚需逐步有序办理退出与变更手续以外，将不在公司担任其他职务。 二、高级管理人员聘任情况 （一）董事会会议召开情况 2025年6月11日，公司以电子邮件和专人送达的方式，向全体董事发出了关于召开通讯董事会的通知以 及《关于调整巩海东同志副总经理职务、聘任刘旭光同志及孙京同志为副总经理的议案》。本次会议以 通讯表决的方式召开，应出席董事11名，实际出席董事11名。会议的召集召开符合《公司法》和《公司 章程》的规定。 （二）董事会会议审议情况 公司董事会提名委员会召开了会议，对该议案发表了同意 ...

Financial Performance - Revenues for Q2 2025 totaled $1.53 billion, down from $1.71 billion year-over-year[4] - Net income decreased by 36% to $107.9 million, with diluted earnings per share declining 30% to $1.50[8] - Total revenues for the three months ended May 31, 2025, were $1,529,585, a decrease of 10.5% compared to $1,709,813 for the same period in 2024[17] - Net income for the three months ended May 31, 2025, was $107,883, representing a decline of 35.8% from $168,419 in 2024[17] - Homebuilding revenues for the six months ended May 31, 2025, were $2,911,757, down 7.8% from $3,159,638 in 2024[21] - Total pretax income for the six months ended May 31, 2025, was $281,740, down 28.8% from $395,784 in 2024[17] - Financial services pretax income for the six months ended May 31, 2025, was $15,687, a decrease of 36.9% from $24,840 in 2024[17] Home Delivery and Orders - Homes delivered decreased by 11% to 3,120 units compared to the previous year[4] - Homes delivered in the three months ended May 31, 2025, totaled 3,120, a decrease of 11.4% from 3,523 in the same period of 2024[23] - Net orders decreased by 13% to 3,460, with an ending backlog of 4,776 homes, down 27% year-over-year[8] - The backlog of homes as of May 31, 2025, was 4,776 homes valued at $2,288,231, down from 6,270 homes valued at $3,122,135 in 2024[23] Pricing and Margins - Average selling price increased slightly to $488,700, reflecting a 3% increase year-over-year[4] - The average selling price for homes in the three months ended May 31, 2025, was $488,700, an increase of 1.4% from $483,000 in 2024[21] - Homebuilding operating income was $131.5 million, with an operating income margin of 8.6%, down from 11.1%[4] - The adjusted housing gross profit margin for the three months ended May 31, 2025, was 19.7%, compared to 21.2% in 2024[25] Liquidity and Financial Position - Total liquidity stood at $1.19 billion, including $308.9 million in cash and cash equivalents[8] - Total assets as of May 31, 2025, were $7,017,596, an increase from $6,936,169 as of November 30, 2024[19] Stock and Guidance - The company repurchased $200 million of common stock at an average price of approximately $54 per share[3] - Guidance for full-year 2025 projects housing revenues between $6.30 billion and $6.50 billion[13] Taxation - The effective tax rate for the quarter was approximately 24.2%, compared to 23.8% in the previous year[8]

成分股孩之宝收涨2.87%，美妆公司e.l.f. Beauty涨2.72%，3M涨2.48%，蔻驰和耐克涨超1.6%。 百思买则收跌1.7%，安德玛A类股跌2.28%，Fluence Energy跌3.60%，Boot Barn跌4.20%。 周一（6月23日），"特朗普关税输家"指数涨0.64%，报95.80点。 ...

SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (“Cidara”) (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $250.0 million of shares of its common stock. All of the shares are being offered by Cidara. In connection with the proposed offering, Cidara expects to grant the underw ...

BOSTON, June 23, 2025 (GLOBE NEWSWIRE) -- Plymouth Industrial REIT, Inc. (NYSE: PLYM) (the “Company” or “Plymouth”) today announced the acquisition of a 1.95-million-square-foot portfolio of industrial properties located across Columbus, Cincinnati, and Cleveland, Ohio for a total purchase price of $193.0 million. The 21-building portfolio comprises highly functional industrial assets with strong infill locations and desirable physical features including high clear heights, ample truck loading, updated ligh ...

Review of promising Myostatin and Activin E antibody data iBio to announce 3rd target in Astral Bio Collaboration Conference call Tuesday, June 24 at 8:30 a.m. ET SAN DIEGO, June 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced the Company will host a conference call on Tuesday, June 24, at 8:30 a.m. ET to review its latest advances in obesity and cardiometabolic disease treatments and announce a third target in the AstralBio Col ...

CARLSBAD, Calif., June 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the execution of an amended credit facility with Wells Fargo Bank, NA (“Wells Fargo”). This amendment modifies the current facility extending the term of the agreement to December 31, 2026 and modifies the borrowing capacity to $10 million. Mark A. Le Doux, Chairman and Chief Executive Offic ...

GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board."We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtroni ...

BETHESDA, MD, June 23, 2025 (GLOBE NEWSWIRE) -- Alset Inc. (NASDAQ:AEI) ("AEI" or the "Company"), a diversified holding company principally engaged through its subsidiaries in the development of smart and sustainable home communities and other property development, financial services, digital transformation technologies, biohealth activities and consumer products, is pleased to announce that its Board of Directors has authorized a new stock repurchase program of up to $1,000,000 of the Company’s outstanding ...